<p>In this episode, Greg and Rob are joined by another SpendMend Pharmacy colleague – Riley Protz, who serves as Director of Optimization. They discuss the impact of referral capture opportunities on 340B Program participation and debate the risks of this strategy in comparison with other strategies, like the application of the “continuum of care” in the patient definition.</p>

In this episode, Greg and Rob are joined by another SpendMend Pharmacy colleague – Riley Protz, who serves as Director of Optimization. They discuss the impact of referral capture opportunities on 340B Program participation and debate the risks of this strategy in comparison with other strategies, like the application of the “continuum of care” in the patient definition.

Ep 5 | Weighing the Risk: Referral Capture vs. Continuum of Care

Pharmacists and healthcare industry leaders Rob ‘Hoopi’ Nahoopii PharmD, MS, ACE and Greg Wilson PharmD, BCPS, ACE dive deeply into the complicated and contentious 340B Program as well as other pressing Pharmacy matters. Special guests and industry experts pop in frequently to add insights from all sides of the discussion. If you serve in the pharmacy sector, this podcast is a must-listen!

Share Ep 5 | Weighing the Risk: Referral Capture vs. Continuum of Care

Sign up to save your podcasts

Ep 5 | Weighing the Risk: Referral Capture vs. Continuum of Care

Ep 5 | Weighing the Risk: Referral Capture vs. Continuum of Care

More shows like 340B Unscripted

Relentless Health Value

The NPR Politics Podcast

The Daily

Up First from NPR

Worklife with Adam Grant

Throughline

Becker’s Healthcare Podcast

Tradeoffs

The Daily Dad

Consider This from NPR

340B Insight

The Daily Punch

Pharmacy Innovators Podcast

Inside 340B Report

340Banter Podcast